These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16300868)

  • 1. Influence of clinical outcome and outcome period definitions on estimates of absolute clinical and economic benefits of influenza vaccination in community dwelling elderly persons.
    Nichol KL; Nordin J; Mullooly J
    Vaccine; 2006 Mar; 24(10):1562-8. PubMed ID: 16300868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of clinical case definitions with differing levels of sensitivity and specificity on estimates of the relative and absolute health benefits of influenza vaccination among healthy working adults and implications for economic analyses.
    Nichol KL; Mendelman P
    Virus Res; 2004 Jul; 103(1-2):3-8. PubMed ID: 15163481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
    Rothberg MB; Rose DN
    Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.
    Nichol KL; Margolis KL; Wuorenma J; Von Sternberg T
    N Engl J Med; 1994 Sep; 331(12):778-84. PubMed ID: 8065407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a clinical prediction rule for hospitalization due to pneumonia or influenza or death during influenza epidemics among community-dwelling elderly persons.
    Hak E; Wei F; Nordin J; Mullooly J; Poblete S; Nichol KL
    J Infect Dis; 2004 Feb; 189(3):450-8. PubMed ID: 14745702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly.
    Nichol KL; Nordin J; Mullooly J; Lask R; Fillbrandt K; Iwane M
    N Engl J Med; 2003 Apr; 348(14):1322-32. PubMed ID: 12672859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of efficacy and economic impact of an influenza vaccination campaign in the personnel of a health care setting].
    Cella MT; Corona G; Tuccillo E; Franco G
    Med Lav; 2005; 96(6):483-9. PubMed ID: 16983973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations.
    Hak E; Nordin J; Wei F; Mullooly J; Poblete S; Strikas R; Nichol KL
    Clin Infect Dis; 2002 Aug; 35(4):370-7. PubMed ID: 12145718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of influenza and pneumococcal vaccinations among elderly people in Japan.
    Cai L; Uchiyama H; Yanagisawa S; Kamae I
    Kobe J Med Sci; 2006; 52(3-4):97-109. PubMed ID: 16855372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annual influenza vaccination in community-dwelling elderly individuals and the risk of lower respiratory tract infections or pneumonia.
    Voordouw BC; Sturkenboom MC; Dieleman JP; Stijnen T; van der Lei J; Stricker BH
    Arch Intern Med; 2006 Oct; 166(18):1980-5. PubMed ID: 17030831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective cost-effectiveness analyses for polio vaccination in the United States.
    Thompson KM; Tebbens RJ
    Risk Anal; 2006 Dec; 26(6):1423-40. PubMed ID: 17184390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could a federal program to promote influenza vaccination among elders be cost-effective?
    Patel MS; Davis MM
    Prev Med; 2006 Mar; 42(3):240-6. PubMed ID: 16480761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older.
    Maciosek MV; Solberg LI; Coffield AB; Edwards NM; Goodman MJ
    Am J Prev Med; 2006 Jul; 31(1):72-9. PubMed ID: 16777545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cost-effectiveness of influenza vaccination The Netherlands].
    Reinders A; Postma MJ; Govaert TM; Sprenger MJ
    Ned Tijdschr Geneeskd; 1997 Jan; 141(2):93-7. PubMed ID: 9036354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and effectiveness of influenza vaccination among Thai elderly persons living in the community.
    Praditsuwan R; Assantachai P; Wasi C; Puthavatana P; Kositanont U
    J Med Assoc Thai; 2005 Feb; 88(2):256-64. PubMed ID: 15962680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives.
    Navas E; Salleras L; Domínguez A; Ibáñez D; Prat A; Sentís J; Garrido P
    Vaccine; 2007 Apr; 25(16):3233-9. PubMed ID: 17324489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An economic analysis of annual influenza vaccination of children.
    Meltzer MI; Neuzil KM; Griffin MR; Fukuda K
    Vaccine; 2005 Jan; 23(8):1004-14. PubMed ID: 15620473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of influenza vaccination of healthy children.
    Salo H; Kilpi T; Sintonen H; Linna M; Peltola V; Heikkinen T
    Vaccine; 2006 Jun; 24(23):4934-41. PubMed ID: 16678945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness and potential impact of rotavirus vaccination in the United States.
    Widdowson MA; Meltzer MI; Zhang X; Bresee JS; Parashar UD; Glass RI
    Pediatrics; 2007 Apr; 119(4):684-97. PubMed ID: 17403839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two vaccination programmes in preventing influenza-related hospitalization among the elderly during two consecutive seasons.
    Honkanen P; Läärä E; Pyhälä R; Kivelä SL; Helena Mäkelä P
    Scand J Infect Dis; 2006; 38(6-7):506-11. PubMed ID: 16798702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.